Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin)
- 31 January 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (1) , 51-54
- https://doi.org/10.1016/0732-8893(94)00116-e
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeaeDiagnostic Microbiology and Infectious Disease, 1994
- Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various national committee for clinical laboratory standards susceptibility test methodsDiagnostic Microbiology and Infectious Disease, 1994
- Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocciAntimicrobial Agents and Chemotherapy, 1994
- Interpretive criteria for DU-6859a disk diffusion tests using 5-μg disksDiagnostic Microbiology and Infectious Disease, 1994
- Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacinDiagnostic Microbiology and Infectious Disease, 1994
- The in-vitro activity of a new highly active quinolone, DU-6859aJournal of Antimicrobial Chemotherapy, 1993
- Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-μg disksDiagnostic Microbiology and Infectious Disease, 1992
- Fluoroquinolone resistance an evolving national problem or just a problem for some physicians?Diagnostic Microbiology and Infectious Disease, 1992
- In vitro activity of AT-4140 against clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1989
- Resistance to ciprofloxacin appearing during therapyThe American Journal of Medicine, 1989